{
  "id": 22,
  "text": "The guidelines aim at covering comprehensively staging, management, and follow-up for patients with cervical cancer.Management includes fertility sparing treatment (FST); stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer (LACC); primary distant metastatic disease; cervical cancer in pregnancy (CCIP); and recurrent disease.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: The guidelines aim at covering comprehensively staging, management, and follow-up for patients with cervical cancer.Management includes fertility sparing treatment (FST); stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer (LACC); primary distant metastatic disease; cervical cancer in pregnancy (CCIP); and recurren\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "宫颈癌合并妊娠（CCIP）的分期、治疗及随访管理需要综合考虑肿瘤分期、孕周及患者意愿。\n\n1. **分期**：  \n   宫颈癌合并妊娠的分期遵循国际妇产肿瘤学会（FIGO）分期标准，通常通过盆腔MRI和胸部影像检查进行评估。对于妊娠期患者，尽可能避免对胎儿有害的检查方法，如放射学检查。\n\n2. **治疗**：\n   - **孕早期（<12周）**：如确诊宫颈癌，视分期和患者选择，可考虑终止妊娠后进行标准治疗。对希望保留妊娠者，需个性化评估肿瘤进展风险。\n   - **孕中期（13-26周）和孕晚期（>26周）**：\n     - **早期宫颈癌（T1a-T1b1）**：可考虑保守治疗（如延迟至胎儿可存活后再行分娩，并随后进行手术或放疗）。锥切术在某些情况下也可以在孕中期选择。\n     - **局部晚期宫颈癌（T1b2-T2a1及更高级别）**：需要高度谨慎管理，多建议新辅助化疗控制肿瘤进展，待胎儿成熟后行剖宫产终止妊娠，并立即开始标准治疗（手术或同步放化疗）。\n   - 对于胎儿存活能力、患者治疗延迟风险和个体化优先级需全面权衡。\n\n3. **分娩方式**：  \n   多数宫颈癌合并妊娠患者建议通过剖宫产分娩，避免经阴道分娩对肿瘤播散的潜在风险。\n\n4. **随访管理**：  \n   治愈后的随访需定期进行，包括影像学检查和肿瘤标志物监测（如SCC抗原），以评估复发风险。此外，对于保留生育能力的治疗，应进一步监测生殖系统功能，并在随访中给予生育指导。\n\n总之，宫颈癌合并妊娠的管理需多学科协作，综合肿瘤学、产科及患者需求制定个体化治疗方案。",
  "query": "宫颈癌患者在妊娠期间（如宫颈癌合并妊娠）应如何进行分期、治疗以及随访管理？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌患者在妊娠期间（如宫颈癌合并妊娠）应如何进行分期、治疗以及随访管理？\n\n<reference text>: The guidelines aim at covering comprehensively staging, management, and follow-up for patients with cervical cancer.Management includes fertility sparing treatment (FST); stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer (LACC); primary distant metastatic disease; cervical cancer in pregnancy (CCIP); and recurrent disease.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "宫颈癌合并妊娠（CCIP）的分期、治疗及随访管理需要综合考虑肿瘤分期、孕周及患者意愿。\n\n1. **分期**：  \n   宫颈癌合并妊娠的分期遵循国际妇产肿瘤学会（FIGO）分期标准，通常通过盆腔MRI和胸部影像检查进行评估。对于妊娠期患者，尽可能避免对胎儿有害的检查方法，如放射学检查。\n\n2. **治疗**：\n   - **孕早期（<12周）**：如确诊宫颈癌，视分期和患者选择，可考虑终止妊娠后进行标准治疗。对希望保留妊娠者，需个性化评估肿瘤进展风险。\n   - **孕中期（13-26周）和孕晚期（>26周）**：\n     - **早期宫颈癌（T1a-T1b1）**：可考虑保守治疗（如延迟至胎儿可存活后再行分娩，并随后进行手术或放疗）。锥切术在某些情况下也可以在孕中期选择。\n     - **局部晚期宫颈癌（T1b2-T2a1及更高级别）**：需要高度谨慎管理，多建议新辅助化疗控制肿瘤进展，待胎儿成熟后行剖宫产终止妊娠，并立即开始标准治疗（手术或同步放化疗）。\n   - 对于胎儿存活能力、患者治疗延迟风险和个体化优先级需全面权衡。\n\n3. **分娩方式**：  \n   多数宫颈癌合并妊娠患者建议通过剖宫产分娩，避免经阴道分娩对肿瘤播散的潜在风险。\n\n4. **随访管理**：  \n   治愈后的随访需定期进行，包括影像学检查和肿瘤标志物监测（如SCC抗原），以评估复发风险。此外，对于保留生育能力的治疗，应进一步监测生殖系统功能，并在随访中给予生育指导。\n\n总之，宫颈癌合并妊娠的管理需多学科协作，综合肿瘤学、产科及患者需求制定个体化治疗方案。"
}